Back to GENZ Stock Lookup

GENZ Related Analyst Comments

May 16, 2011 02:05 PM Global Pharmaceuticals: Global Therapeutic Conference 2011: Focus on Real-World Medicine

Mar 23, 2011 10:37 AM Canaccord Genuity Morning Coffee on Merck & Co. (MRK) and Sanofi-Aventis (SNY): So Long, Farewell, Au Revoir

Feb 18, 2011 10:00 AM Jefferies Cuts Estimate & Raises Price Target on BioMarin Pharmaceutical (BMRN), Maintains Buy Rating

Feb 17, 2011 10:34 AM Canaccord Genuity Morning Coffee on Sanofi-Aventis (SNY) and Genzyme (GENZ): An Extra $5 Will Help The Medicine Go Down

Jan 12, 2011 01:46 PM Barclays Maintains an 'Equalweight' on Genzyme (GENZ); Slightly Weaker Results, Focus Remains on Sanofi Process

Jan 12, 2011 12:19 PM Protalix BioTherapeutics (PLX) Rebounds On Path to FDA Approval

Jan 11, 2011 07:49 AM Needham & Company Reiterates a 'Hold' on ISIS Pharmaceuticals (ISIS); FDA Views Mipomersen Data as Sufficient to Submit HoFH NDA

Nov 30, 2010 08:38 AM Ticonderoga Maintains a 'Neutral' on Evercore Partners (EVR); Dynegy Breakdown Highlights "Key Deal" Risk for EVR

Nov 9, 2010 11:16 AM Canaccord Genuity Maintains a 'Buy' on Amicus Therapeutics (FOLD); Rolling Out New Amigal Trials With GSK's Support

Oct 21, 2010 09:19 AM Morgan Joseph Reiterates a 'Buy' Rating on Genzyme (GENZ); Continue To Like Fundamentals

Sep 13, 2010 12:01 PM Deutsche Bank Maintains a 'Hold' on Genzyme (GENZ); Genetics Sale-More Upside if Diagnostics Sold

Aug 31, 2010 06:16 AM Citigroup Sees Sanofi (SNY) Paying $74-$77 for Genzyme (GENZ)

Aug 30, 2010 05:23 PM Olympia Capital End of Day Summary: Stocks Slide as Trade Turns Cautious

Jul 27, 2010 09:37 AM Morgan Joseph Adds Onyx Pharma (ONXX) to 'Trading List' Following Positive Data on Carfilzomib

Jul 26, 2010 08:27 AM Wall Street Aflutter With Genzyme (GENZ) Takeover Speculation

Jul 22, 2010 12:49 PM Genzyme (GENZ) Target Edged Higher to $73 at Piper Jaffray

Jul 19, 2010 07:28 AM Piper Jaffray Maintains an 'Overweight' Rating on Genzyme (GENZ); Lowering Price Target

Jul 12, 2010 12:14 PM Leerink Swann Says M&A Is One Reason To Get Involved In Biophama (AGN, DNDN, BMRN, HGSI, more...)

Jun 30, 2010 11:29 AM Citi Maintains a 'Buy' on Genzyme (GENZ); Manufacturing Saga Continues- Cerezyme On Track, But Fabrazyme Lost

May 27, 2010 10:26 AM Citi Announces Highlights from Recent Healthcare Conference

May 7, 2010 07:29 AM Piper Jaffray Reiterates an 'Overweight' Rating on Genzyme (GENZ); Making the Right Moves

Apr 22, 2010 10:07 AM Morgan Joseph Reiterates a 'Buy' on Genzyme (GENZ); Favorable Risk Reward

Mar 16, 2010 12:59 PM Study Shows Record $65 billion Spent by U.S. Biopharmaceutical Companies in R&D

Feb 18, 2010 08:06 AM Morgan Joseph Reiterates a 'Buy' Rating on Genzyme (GENZ)

Feb 17, 2010 11:13 AM Merriman Curhan Ford Maintains a 'Buy' on Cyclacel Pharmaceuticals (CYCC); Raises PT Range

Feb 8, 2010 07:33 AM Goldman Sachs Removed Genzyme (GENZ) from Conviction Sell List, Adds St. Jude (STJ)

Feb 1, 2010 09:33 AM Morgan Joseph Adds Spectrum Pharmaceuticals (SPPI) to Trading List; Expect Strong Growth From Zevalin

Dec 2, 2009 08:30 AM Hapoalim Securities Reiterates a 'Buy' on Protalix (PLX); Raises PT in Wake of Pfizer (PFE) Deal

Dec 1, 2009 11:51 AM Baird Reiterates a 'Neutral' Rating on Genzyme (GENZ); Long-Term Implications Still Evolving

Nov 27, 2009 11:27 AM Canaccord Adams Maintains a 'Buy' on Protalix BioTherapeutics (PLX); Cerezyme Supply on Track, See More Uplyso EAP Uptake

Nov 18, 2009 08:16 AM Morgan Joseph Reiterates a 'Buy' on Isis Pharmaceuticals (ISIS); Could Be Acquired by Potential Partners

Nov 18, 2009 07:30 AM Piper Jaffray Maintains an 'Overweight' on ISIS Pharmaceuticals (ISIS); Price Target Cut

Nov 13, 2009 02:16 PM Goldman Sachs Says FDA News on Genzyme (GENZ) is a "Significant Negative Surprise"

Nov 13, 2009 12:43 PM Deutsche Bank Says Genzyme (GENZ) FDA Warning May Not Be a Big Deal

Sep 23, 2009 03:16 PM Wells Fargo Says Genzyme (GENZ) Guidance Eliminates Overhang; Maintains Outperform, But Lowers Estimates

Aug 31, 2009 06:53 AM Genzyme (GENZ): Colour on Allston problems

Aug 24, 2009 09:13 AM Collins Stewart Cuts Price Target on Genzyme (GENZ) to $63, But Reiterates Buy

Aug 7, 2009 07:24 AM Goldman Sachs Added Genzyme (GENZ) to its Conviction Sell List

Jul 6, 2009 12:00 PM Protalix BioTherapeutics (PLX) Gets Huge Opportunity Due To Genzyme's (GENZ) Plant Shut-Down

Jun 26, 2009 08:19 AM Goldman Sachs Lowers Price Target On Genzyme (GENZ); Maintains Sell

Jun 16, 2009 09:55 AM Baird Is a Buyer of BioMarin (BMRN) On Genzyme-Related Weakness

Mar 19, 2009 07:51 AM Baird Said a Genzyme (GENZ) Takeover Of BioMarin (BMRN) Makes Sense To Them

Sep 22, 2008 03:33 PM Deutsche Bank Comments on Genzyme (GENZ) Related to FX Exposure

Jan 15, 2008 08:44 AM Wachovia raises its valuation range on Genzyme (GENZ) to $90-$95

Jan 14, 2008 10:20 AM BWS Financial Says ISIS Pharma (ISIS) Could Goto $30

Jan 8, 2008 08:58 AM Analyst Firms Raise Price Targets on ISIS Pharmaceuticals (ISIS)

Dec 13, 2007 11:21 AM Baird Said Myozyme Study Success Removes Major Overhang for Genzyme (GENZ)

Oct 17, 2007 02:11 PM Analyst Sees Biogen and ImClone as Likely M&A Targets and To a Lesser Extent Genzyme

Sep 26, 2007 08:53 AM Baird on Genzyme (GENZ) - Actionable

Jun 14, 2007 09:31 AM Deutsche Bank Reiterates Their Buy Rating on Genzyme (GENZ)

Back to GENZ Stock Lookup